Coronary Angioplasty with or without Stent Implantation for Acute Myocardial Infarction
Cindy L. Grines, M.D., David A. Cox, M.D., Gregg W. Stone, M.D., Eulogio Garcia, M.D., Luiz A. Mattos, M.D., Alessandro Giambartolomei, M.D., Bruce R. Brodie, M.D., Olivier Madonna, M.D., Marcel Eijgelshoven, Ph.D., Alexandra J. Lansky, M.D., William W. O'Neill, M.D., Marie-Claude Morice, M.D., for The Stent Primary Angioplasty in Myocardial Infarction Study Group
Background Coronary-stent implantation is frequently performedfor treatment of acute myocardial infarction. However, few studieshave compared stent implantation with primary angioplasty alone.
Methods We designed a multicenter study to compare primary angioplastywith angioplasty accompanied by implantation of a heparin-coatedPalmazSchatz stent. Patients with acute myocardial infarctionunderwent emergency catheterization and angioplasty. Those withvessels suitable for stenting were randomly assigned to undergoangioplasty with stenting (452 patients) or angioplasty alone(448 patients).
Results The mean (±SD) minimal luminal diameter was largerafter stenting than after angioplasty alone (2.56±0.44mm vs. 2.12±0.45 mm, P<0.001), although fewer patientsassigned to stenting had grade 3 blood flow (according to theclassification of the Thrombolysis in Myocardial Infarctiontrial) (89.4 percent, vs. 92.7 percent in the angioplasty group;P=0.10). After six months, fewer patients in the stent groupthan in the angioplasty group had angina (11.3 percent vs. 16.9percent, P=0.02) or needed target-vessel revascularization becauseof ischemia (7.7 percent vs. 17.0 percent, P<0.001). In addition,the combined primary end point of death, reinfarction, disablingstroke, or target-vessel revascularization because of ischemiaoccurred in fewer patients in the stent group than in the angioplastygroup (12.6 percent vs. 20.1 percent, P<0.01). The decreasein the combined end point was due entirely to the decreasedneed for target-vessel revascularization. The six-month mortalityrates were 4.2 percent in the stent group and 2.7 percent inthe angioplasty group (P=0.27). Angiographic follow-up at 6.5months demonstrated a lower incidence of restenosis in the stentgroup than in the angioplasty group (20.3 percent vs. 33.5 percent,P<0.001).
Conclusions In patients with acute myocardial infarction, routineimplantation of a stent has clinical benefits beyond those ofprimary coronary angioplasty alone.
Source Information
From the Division of Cardiology, William Beaumont Hospital, Royal Oak, Mich. (C.L.G., W.W.O.); Mid Carolina Cardiology, Charlotte, N.C. (D.A.C.); Washington Hospital Center, Washington, D.C. (G.W.S., A.J.L.); Hospital Gregorio Maranon, Madrid (E.G.); Instituto Dante Pazzanese de Cardiologia, São Paulo, Brazil (L.A.M.); St. Joseph's Hospital, Syracuse, N.Y. (A.G.); LeBauer Health Care, Greensboro, N.C. (B.R.B.); Cordis, Johnson & Johnson, Paris (O.M.); Cardialysis, Rotterdam, the Netherlands (M.E.); and Institut Cardiovasculaire Paris Sud, Antony, France (M.-C.M.).
Address reprint requests to Dr. Grines at the Cardiac Catheterization Laboratories, William Beaumont Hospital, 3601 W. Thirteen Mile Rd., Royal Oak, MI 48073-6769.
Maehara, A., Mintz, G. S., Lansky, A. J., Witzenbichler, B., Guagliumi, G., Brodie, B., Kellett, M. A. Jr, Parise, H., Mehran, R., Stone, G. W.
(2009). Volumetric Intravascular Ultrasound Analysis of Paclitaxel-Eluting and Bare Metal Stents in Acute Myocardial Infarction: The Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction Intravascular Ultrasound Substudy. Circulation
120: 1875-1882
[Abstract][Full Text]
Levy, E. I., Siddiqui, A. H., Crumlish, A., Snyder, K. V., Hauck, E. F., Fiorella, D. J., Hopkins, L. N., Mocco, J
(2009). First Food and Drug Administration-Approved Prospective Trial of Primary Intracranial Stenting for Acute Stroke: SARIS (Stent-Assisted Recanalization in Acute Ischemic Stroke). Stroke
40: 3552-3556
[Abstract][Full Text]
Shaw, L. J., Bugiardini, R., Merz, C. N. B.
(2009). Women and ischemic heart disease: evolving knowledge.. J Am Coll Cardiol
54: 1561-1575
[Abstract][Full Text]
Camici, G. G., Steffel, J., Amanovic, I., Breitenstein, A., Baldinger, J., Keller, S., Luscher, T. F., Tanner, F. C.
(2009). Rapamycin promotes arterial thrombosis in vivo: implications for everolimus and zotarolimus eluting stents. Eur Heart J
0: ehp259v1-ehp259
[Abstract][Full Text]
Brekenfeld, C., Tinguely, P., Schroth, G., Arnold, M., El-Koussy, M., Nedeltchev, K., Byrne, J.V., Gralla, J.
(2009). Percutaneous Transluminal Angioplasty and Stent Placement in Acute Vessel Occlusion: Evaluation of New Methods for Interventional Stroke Treatment. Am. J. Neuroradiol.
30: 1165-1172
[Abstract][Full Text]
Guagliumi, G.
(2009). Emerging data and decision for optimizing STEMI management: the European perspective. Eur Heart J Suppl
11: C19-C24
[Abstract][Full Text]
Marenzi, G., Assanelli, E., Campodonico, J., Lauri, G., Marana, I., De Metrio, M., Moltrasio, M., Grazi, M., Rubino, M., Veglia, F., Fabbiocchi, F., Bartorelli, A. L.
(2009). Contrast Volume During Primary Percutaneous Coronary Intervention and Subsequent Contrast-Induced Nephropathy and Mortality. ANN INTERN MED
150: 170-177
[Abstract][Full Text]
Stahli, B. E., Camici, G. G., Tanner, F. C.
(2009). Drug-eluting stent thrombosis. Ther Adv Cardiovasc Dis
3: 45-52
[Abstract]
Mehta, R. H., Ou, F.-S., Peterson, E. D., Shaw, R. E., Hillegass, W. B. Jr, Rumsfeld, J. S., Roe, M. T., American College of Cardiology-National Cardiovasc,
(2009). Clinical Significance of Post-Procedural TIMI Flow in Patients With Cardiogenic Shock Undergoing Primary Percutaneous Coronary Intervention. J Am Coll Cardiol Intv
2: 56-64
[Abstract][Full Text]
Hamm, C. W., Möllmann, H., Bassand, J.-P., van de Werf, F.
(2009). CHAPTER 16 Acute Coronary Syndromes. ESC Textbook of Cardiovascular Medicine
2: med-9780199566990-chapter-med-9780199566990-chapter
[Abstract][Full Text]
Authors/Task Force Members, , Van de Werf, F., Bax, J., Betriu, A., Blomstrom-Lundqvist, C., Crea, F., Falk, V., Filippatos, G., Fox, K., Huber, K., Kastrati, A., Rosengren, A., Steg, P. G., Tubaro, M., Verheugt, F., Weidinger, F., Weis, M., ESC Committee for Practice Guidelines (CPG), , Vahanian, A., Camm, J., De Caterina, R., Dean, V., Dickstein, K., Filippatos, G., Funck-Brentano, C., Hellemans, I., Kristensen, S. D., McGregor, K., Sechtem, U., Silber, S., Tendera, M., Widimsky, P., Zamorano, J. L., Document Reviewers, , Silber, S., Aguirre, F. V., Al-Attar, N., Alegria, E., Andreotti, F., Benzer, W., Breithardt, O., Danchin, N., Mario, C. D., Dudek, D., Gulba, D., Halvorsen, S., Kaufmann, P., Kornowski, R., Lip, G. Y. H., Rutten, F.
(2008). Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: The Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology:. Eur Heart J
29: 2909-2945
[Full Text]
Buller, C. E., Fu, Y., Mahaffey, K. W., Todaro, T. G., Adams, P., Westerhout, C. M., White, H. D., van 't Hof, A. W.J., Van de Werf, F. J., Wagner, G. S., Granger, C. B., Armstrong, P. W.
(2008). ST-Segment Recovery and Outcome After Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction: Insights From the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) Trial. Circulation
118: 1335-1346
[Abstract][Full Text]
Kelbaek, H., Thuesen, L., Helqvist, S., Clemmensen, P., Klovgaard, L., Kaltoft, A., Andersen, B., Thuesen, H., Engstrom, T., Botker, H. E., Saunamaki, K., Krusell, L. R., Jorgensen, E., Hansen, H.-H. T., Christiansen, E. H., Ravkilde, J., Kober, L., Kofoed, K. F., Terkelsen, C. J., Lassen, J. F., for the DEDICATION Investigators,
(2008). Drug-Eluting Versus Bare Metal Stents in Patients With ST-Segment-Elevation Myocardial Infarction: Eight-Month Follow-Up in the Drug Elution and Distal Protection in Acute Myocardial Infarction (DEDICATION) Trial. Circulation
118: 1155-1162
[Abstract][Full Text]
Martin-Rendon, E., Brunskill, S. J., Hyde, C. J., Stanworth, S. J., Mathur, A., Watt, S. M.
(2008). Autologous bone marrow stem cells to treat acute myocardial infarction: a systematic review. Eur Heart J
29: 1807-1818
[Abstract][Full Text]
Heyer, E. J., Gold, M. I., Kirby, E. W., Zurica, J., Mitchell, E., Halazun, H. J., Teverbaugh, L., Sciacca, R. R., Solomon, R. A., Quest, D. O., Maldonado, T. S., Riles, T. S., Connolly, E. S. Jr
(2008). A Study of Cognitive Dysfunction in Patients Having Carotid Endarterectomy Performed with Regional Anesthesia. Anesth. Analg.
107: 636-642
[Abstract][Full Text]
Lee, M. S., Tseng, C.-H., Barker, C. M., Menon, V., Steckman, D., Shemin, R., Hochman, J. S.
(2008). Outcome After Surgery and Percutaneous Intervention for Cardiogenic Shock and Left Main Disease. Ann. Thorac. Surg.
86: 29-34
[Abstract][Full Text]
Pineda, V., Merino, X., Gispert, S., Mahia, P., Garcia, B., Dominguez-Oronoz, R.
(2008). No-Reflow Phenomenon in Cardiac MRI: Diagnosis and Clinical Implications. Am. J. Roentgenol.
191: 73-79
[Abstract][Full Text]
Jaffe, R., Charron, T., Puley, G., Dick, A., Strauss, B. H.
(2008). Microvascular Obstruction and the No-Reflow Phenomenon After Percutaneous Coronary Intervention. Circulation
117: 3152-3156
[Full Text]
Goodman, S. G., Menon, V., Cannon, C. P., Steg, G., Ohman, E. M., Harrington, R. A.
(2008). Acute ST-Segment Elevation Myocardial Infarction: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest
133: 708S-775S
[Abstract][Full Text]
Grines, C. L., Goldstein, J. A., Safian, R. D.
(2008). Should We Routinely Use Drug-Eluting Stents for Acute Myocardial Infarction?: Let's Wait and See. J Am Coll Cardiol Intv
1: 136-138
[Full Text]
Sianos, G., Papafaklis, M. I., Daemen, J., Vaina, S., van Mieghem, C. A., van Domburg, R. T., Michalis, L. K., Serruys, P. W.
(2008). Reply.. J Am Coll Cardiol
51: 1047-1047
[Full Text]
van der Hoeven, B. L., Liem, S.-S., Jukema, J. W., Suraphakdee, N., Putter, H., Dijkstra, J., Atsma, D. E., Bootsma, M., Zeppenfeld, K., Oemrawsingh, P. V., van der Wall, E. E., Schalij, M. J.
(2008). Sirolimus-eluting stents versus bare-metal stents in patients with ST-segment elevation myocardial infarction: 9-month angiographic and intravascular ultrasound results and 12-month clinical outcome results from the MISSION! Intervention Study.. J Am Coll Cardiol
51: 618-626
[Abstract][Full Text]
Wilson, J. M., Willerson, J. T.
(2008). Myocardial Revascularization with Percutaneous Devices. Card Surg Adult
3: 573-598
[Full Text]
George, I., Oz, M. C.
(2008). Myocardial Revascularization after Acute Myocardial Infarction. Card Surg Adult
3: 669-696
[Full Text]
Brasselet, C., Tassan, S., Nazeyrollas, P., Hamon, M., Metz, D.
(2007). Randomised comparison of femoral versus radial approach for percutaneous coronary intervention using abciximab in acute myocardial infarction: results of the FARMI Trial. Heart
93: 1556-1561
[Abstract][Full Text]
Kawaguchi, R., Oshima, S., Jingu, M., Tsurugaya, H., Toyama, T., Hoshizaki, H., Taniguchi, K.
(2007). Usefulness of Virtual Histology Intravascular Ultrasound to Predict Distal Embolization for ST-Segment Elevation Myocardial Infarction. J Am Coll Cardiol
50: 1641-1646
[Abstract][Full Text]
Sianos, G., Papafaklis, M. I., Daemen, J., Vaina, S., van Mieghem, C. A., van Domburg, R. T., Michalis, L. K., Serruys, P. W.
(2007). Angiographic Stent Thrombosis After Routine Use of Drug-Eluting Stents in ST-Segment Elevation Myocardial Infarction: The Importance of Thrombus Burden. J Am Coll Cardiol
50: 573-583
[Abstract][Full Text]
Sorajja, P., Gersh, B. J., Cox, D. A., McLaughlin, M. G., Zimetbaum, P., Costantini, C., Stuckey, T., Tcheng, J. E., Mehran, R., Lansky, A. J., Grines, C. L., Stone, G. W.
(2007). Impact of multivessel disease on reperfusion success and clinical outcomes in patients undergoing primary percutaneous coronary intervention for acute myocardial infarction. Eur Heart J
28: 1709-1716
[Abstract][Full Text]
Svilaas, T., van der Horst, I. C C, Zijlstra, F.
(2007). A quantitative estimate of bare-metal stenting compared with balloon angioplasty in patients with acute myocardial infarction: angiographic measures in relation to clinical outcome. Heart
93: 792-800
[Abstract][Full Text]
Menichelli, M., Parma, A., Pucci, E., Fiorilli, R., De Felice, F., Nazzaro, M., Giulivi, A., Alborino, D., Azzellino, A., Violini, R.
(2007). Randomized Trial of Sirolimus-Eluting Stent Versus Bare-Metal Stent in Acute Myocardial Infarction (SESAMI). J Am Coll Cardiol
49: 1924-1930
[Abstract][Full Text]
Keeley, E. C., Hillis, L. D.
(2007). Primary PCI for Myocardial Infarction with ST-Segment Elevation. NEJM
356: 47-54
[Full Text]
Dzau, V. J., Antman, E. M., Black, H. R., Hayes, D. L., Manson, J. E., Plutzky, J., Popma, J. J., Stevenson, W.
(2006). The Cardiovascular Disease Continuum Validated: Clinical Evidence of Improved Patient Outcomes: Part II: Clinical Trial Evidence (Acute Coronary Syndromes Through Renal Disease) and Future Directions. Circulation
114: 2871-2891
[Full Text]
Levy, E.I., Sauvageau, E., Hanel, R.A., Parikh, R., Hopkins, L.N.
(2006). Self-Expanding Versus Balloon-Mounted Stents for Vessel Recanalization Following Embolic Occlusion in the Canine Model: Technical Feasibility Study. Am. J. Neuroradiol.
27: 2069-2072
[Abstract][Full Text]
Coca, S. G., Krumholz, H. M., Garg, A. X., Parikh, C. R.
(2006). Underrepresentation of renal disease in randomized controlled trials of cardiovascular disease.. JAMA
296: 1377-1384
[Abstract][Full Text]
Spaulding, C., Henry, P., Teiger, E., Beatt, K., Bramucci, E., Carrie, D., Slama, M. S., Merkely, B., Erglis, A., Margheri, M., Varenne, O., Cebrian, A., Stoll, H.-P., Snead, D. B., Bode, C., the TYPHOON Investigators,
(2006). Sirolimus-Eluting versus Uncoated Stents in Acute Myocardial Infarction. NEJM
355: 1093-1104
[Abstract][Full Text]
Laarman, G. J., Suttorp, M. J., Dirksen, M. T., van Heerebeek, L., Kiemeneij, F., Slagboom, T., van der Wieken, L. R., Tijssen, J. G.P., Rensing, B. J., Patterson, M.
(2006). Paclitaxel-Eluting versus Uncoated Stents in Primary Percutaneous Coronary Intervention. NEJM
355: 1105-1113
[Abstract][Full Text]
Wong, C.-K., Gao, W., Stewart, R. A.H., van Pelt, N., French, J. K., Aylward, P. E.G., White, H. D., on behalf of the Hirulog Early Reperfusion Occlusi,
(2006). Risk Stratification of Patients With Acute Anterior Myocardial Infarction and Right Bundle-Branch Block: Importance of QRS Duration and Early ST-Segment Resolution After Fibrinolytic Therapy. Circulation
114: 783-789
[Abstract][Full Text]
Stahli, B. E., Camici, G. G., Steffel, J., Akhmedov, A., Shojaati, K., Graber, M., Luscher, T. F., Tanner, F. C.
(2006). Paclitaxel Enhances Thrombin-Induced Endothelial Tissue Factor Expression via c-Jun Terminal NH2 Kinase Activation. Circ. Res.
99: 149-155
[Abstract][Full Text]
Ali, A., Cox, D., Dib, N., Brodie, B., Berman, D., Gupta, N., Browne, K., Iwaoka, R., Azrin, M., Stapleton, D., Setum, C., Popma, J., for the AIMI Investigators,
(2006). Rheolytic Thrombectomy With Percutaneous Coronary Intervention for Infarct Size Reduction in Acute Myocardial Infarction: 30-Day Results From a Multicenter Randomized Study. J Am Coll Cardiol
48: 244-252
[Abstract][Full Text]
Tung, R., Kaul, S., Diamond, G. A., Shah, P. K.
(2006). Narrative review: drug-eluting stents for the management of restenosis: a critical appraisal of the evidence.. ANN INTERN MED
144: 913-919
[Abstract][Full Text]
Gray, D
(2006). Thrombolysis: past, present, and future.. Postgrad. Med. J.
82: 372-375
[Abstract][Full Text]
De Luca, G., Suryapranata, H., Timmer, J., Ottervanger, J. P., van't Hof, A. W.J., Hoorntje, J. C.A., Dambrink, J.-H., Gosselink, A.T. M., de Boer, M.-J.
(2006). Impact of Routine Stenting on Clinical Outcome in Diabetic Patients Undergoing Primary Angioplasty for ST-Segment Elevation Myocardial Infarction. Diabetes Care
29: 920-923
[Full Text]
Gupta, R., Vora, N. A., Horowitz, M. B., Tayal, A. H., Hammer, M. D., Uchino, K., Levy, E. I., Wechsler, L. R., Jovin, T. G.
(2006). Multimodal Reperfusion Therapy for Acute Ischemic Stroke: Factors Predicting Vessel Recanalization. Stroke
37: 986-990
[Abstract][Full Text]
Kim, W., Jeong, M. H., Kim, K. H., Sohn, I. S., Hong, Y. J., Park, H. W., Kim, J. H., Ahn, Y. K., Cho, J. G., Park, J. C., Cho, D. L., Kang, J. C.
(2006). The Clinical Results of a Platelet Glycoprotein IIb/IIIa Receptor Blocker (Abciximab: ReoPro)-Coated Stent in Acute Myocardial Infarction. J Am Coll Cardiol
47: 933-938
[Abstract][Full Text]
Serruys, P. W., Kutryk, M. J.B., Ong, A. T.L.
(2006). Coronary-Artery Stents. NEJM
354: 483-495
[Full Text]
The ADMIRAL Investigators,
(2005). Three-year duration of benefit from abciximab in patients receiving stents for acute myocardial infarction in the randomized double-blind ADMIRAL study. Eur Heart J
26: 2520-2523
[Abstract][Full Text]
Smith, E J, Mathur, A, Rothman, M T
(2005). Recent advances in primary percutaneous intervention for acute myocardial infarction. Heart
91: 1533-1536
[Full Text]
Wharton, T. P. Jr, Keeley, E. C., Grines, C. L., Wharton, T. P. Jr, Keeley, E. C., Grines, C. L.
(2005). The Case for Community Hospital Angioplasty. Circulation
112: 3509-3534
[Full Text]
Bilge, A. K., Nisanci, Y., Yilmaz, E., Ozben, B., Oncul, A., Mercanoglu, F., Meric, M.
(2005). Effects of Percutaneous Coronary Thrombectomywith the X-Sizer Catheter on Epicardial Flow and Microvascular Function in Acute Coronary Syndromes. CLIN APPL THROMB HEMOST
11: 461-466
[Abstract]
Hang, C.-L., Wang, C.-P., Yip, H.-K., Yang, C.-H., Guo, G. B.-F., Wu, C.-J., Chen, S.-M.
(2005). Early Administration of Intracoronary Verapamil Improves Myocardial Perfusion During Percutaneous Coronary Interventions for Acute Myocardial Infarction. Chest
128: 2593-2598
[Abstract][Full Text]
Abbate, A., Bussani, R., Biondi-Zoccai, G. G.L., Santini, D., Petrolini, A., Giorgio, F. D., Vasaturo, F., Scarpa, S., Severino, A., Liuzzo, G., Leone, A. M., Baldi, F., Sinagra, G., Silvestri, F., Vetrovec, G. W., Crea, F., Biasucci, L. M., Baldi, A.
(2005). Infarct-related artery occlusion, tissue markers of ischaemia, and increased apoptosis in the peri-infarct viable myocardium. Eur Heart J
26: 2039-2045
[Abstract][Full Text]
Huber, K., Caterina, R. D., Kristensen, S. D., Verheugt, F. W.A., Montalescot, G., Maestro, L. B., Werf, F. V. d., for the Task Force on Pre-hospital Reperfusion The,
(2005). Pre-hospital reperfusion therapy: a strategy to improve therapeutic outcome in patients with ST-elevation myocardial infarction. Eur Heart J
26: 2063-2074
[Full Text]
Migliorini, A., Antoniucci, D.
(2005). Patient selection bias in primary percutaneous coronary intervention trials: a critical issue. Eur Heart J Suppl
7: I21-I26
[Abstract][Full Text]
Steffel, J., Latini, R. A., Akhmedov, A., Zimmermann, D., Zimmerling, P., Luscher, T. F., Tanner, F. C.
(2005). Rapamycin, but Not FK-506, Increases Endothelial Tissue Factor Expression: Implications for Drug-Eluting Stent Design. Circulation
112: 2002-2011
[Abstract][Full Text]
De Luca, G., Suryapranata, H., Grimaldi, R., Chiariello, M.
(2005). Coronary stenting and abciximab in primary angioplasty for ST-segment-elevation myocardial infarction. QJM
98: 633-641
[Abstract][Full Text]
Mizote, I., Ueda, Y., Ohtani, T., Shimizu, M., Takeda, Y., Oka, T., Tsujimoto, M., Hirayama, A., Hori, M., Kodama, K.
(2005). Distal Protection Improved Reperfusion and Reduced Left Ventricular Dysfunction in Patients With Acute Myocardial Infarction Who Had Angioscopically Defined Ruptured Plaque. Circulation
112: 1001-1007
[Abstract][Full Text]
Lefevre, T., Garcia, E., Reimers, B., Lang, I., di Mario, C., Colombo, A., Neumann, F.-J., Chavarri, M. V., Brunel, P., Grube, E., Thomas, M., Glatt, B., Ludwig, J., on behalf of the X AMINE ST Investigators,
(2005). X-Sizer for Thrombectomy in Acute Myocardial Infarction Improves ST-Segment Resolution: Results of the X-Sizer in AMI for Negligible Embolization and Optimal ST Resolution (X AMINE ST) Trial. J Am Coll Cardiol
46: 246-252
[Abstract][Full Text]
Ilkay, E., Karaca, I., Yavuzkir, M., Akbulut, M., Pekdemir, M.
(2005). The Effect of Interventional Treatment in Acute Myocardial Infarction on ST Resolution: A Comparison of Coronary Angioplasty with Excimer Laser Angioplasty. ANGIOLOGY
56: 377-384
[Abstract]
Valgimigli, M., Percoco, G., Malagutti, P., Campo, G., Ferrari, F., Barbieri, D., Cicchitelli, G., McFadden, E. P., Merlini, F., Ansani, L., Guardigli, G., Bettini, A., Parrinello, G., Boersma, E., Ferrari, R., for the STRATEGY Investigators,
(2005). Tirofiban and Sirolimus-Eluting Stent vs Abciximab and Bare-Metal Stent for Acute Myocardial Infarction: A Randomized Trial. JAMA
293: 2109-2117
[Abstract][Full Text]
Cohen, M. G., Ohman, E. M.
(2005). Drug-Eluting Stents in Acute Myocardial Infarction: Is Science Catching Up With Practice?. JAMA
293: 2154-2156
[Full Text]
Halkin, A., Singh, M., Nikolsky, E., Grines, C. L., Tcheng, J. E., Garcia, E., Cox, D. A., Turco, M., Stuckey, T. D., Na, Y., Lansky, A. J., Gersh, B. J., O'Neill, W. W., Mehran, R., Stone, G. W.
(2005). Prediction of Mortality After Primary Percutaneous Coronary Intervention for Acute Myocardial Infarction: The CADILLAC Risk Score. J Am Coll Cardiol
45: 1397-1405
[Abstract][Full Text]
Sciagra, R., Parodi, G., Pupi, A., Migliorini, A., Valenti, R., Moschi, G., Santoro, G. M., Memisha, G., Antoniucci, D.
(2005). Gated SPECT Evaluation of Outcome After Abciximab-Supported Primary Infarct Artery Stenting for Acute Myocardial Infarction: The Scintigraphic Data of the Abciximab and Carbostent Evaluation (ACE) Randomized Trial. JNM
46: 722-727
[Abstract][Full Text]
Suryapranata, H, De Luca, G, van 't Hof, A W J, Ottervanger, J P, Hoorntje, J C A, Dambrink, J-H E, Gosselink, A T M, Zijlstra, F, de Boer, M-J
(2005). Is routine stenting for acute myocardial infarction superior to balloon angioplasty? A randomised comparison in a large cohort of unselected patients. Heart
91: 641-645
[Abstract][Full Text]
Authors/Task Force Members, , Silber, S., Albertsson, P., Aviles, F. F., Camici, P. G., Colombo, A., Hamm, C., Jorgensen, E., Marco, J., Nordrehaug, J.-E., Ruzyllo, W., Urban, P., Stone, G. W., Wijns, W.
(2005). Guidelines for Percutaneous Coronary Interventions: The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology. Eur Heart J
26: 804-847
[Full Text]
Maier, W., Altwegg, L. A., Corti, R., Gay, S., Hersberger, M., Maly, F. E., Sutsch, G., Roffi, M., Neidhart, M., Eberli, F. R., Tanner, F. C., Gobbi, S., von Eckardstein, A., Luscher, T. F.
(2005). Inflammatory Markers at the Site of Ruptured Plaque in Acute Myocardial Infarction: Locally Increased Interleukin-6 and Serum Amyloid A but Decreased C-Reactive Protein. Circulation
111: 1355-1361
[Abstract][Full Text]
Stone, G. W., Webb, J., Cox, D. A., Brodie, B. R., Qureshi, M., Kalynych, A., Turco, M., Schultheiss, H. P., Dulas, D., Rutherford, B. D., Antoniucci, D., Krucoff, M. W., Gibbons, R. J., Jones, D., Lansky, A. J., Mehran, R., for the Enhanced Myocardial Efficacy and Recovery,
(2005). Distal Microcirculatory Protection During Percutaneous Coronary Intervention in Acute ST-Segment Elevation Myocardial Infarction: A Randomized Controlled Trial. JAMA
293: 1063-1072
[Abstract][Full Text]
Lansky, A. J., Hochman, J. S., Ward, P. A., Mintz, G. S., Fabunmi, R., Berger, P. B., New, G., Grines, C. L., Pietras, C. G., Kern, M. J., Ferrell, M., Leon, M. B., Mehran, R., White, C., Mieres, J. H., Moses, J. W., Stone, G. W., Jacobs, A. K., Endorsed by the American College of Cardiology Fou,
(2005). Percutaneous Coronary Intervention and Adjunctive Pharmacotherapy in Women: A Statement for Healthcare Professionals From the American Heart Association. Circulation
111: 940-953
[Abstract][Full Text]
Schomig, A., Ndrepepa, G., Mehilli, J., Dirschinger, J., Nekolla, S. G., Schmitt, C., Martinoff, S., Seyfarth, M., Schwaiger, M., Kastrati, A., STOPAMI-4 Study Investigators{section},
(2004). A randomized trial of coronary stenting versus balloon angioplasty as a rescue intervention after failed thrombolysis in patients with acute myocardial infarction. J Am Coll Cardiol
44: 2073-2079
[Abstract][Full Text]
Heggunje, P. S., Harjai, K. J., Stone, G. W., Mehta, R. H., Marsalese, D. L., Boura, J. A., O'Neill, W. W., Grines, C. L.
(2004). Procedural success versus clinical risk status in determining discharge of patients after primary angioplasty for acute myocardial infarction. J Am Coll Cardiol
44: 1400-1407
[Abstract][Full Text]
Menon, V., Harrington, R. A., Hochman, J. S., Cannon, C. P., Goodman, S. D., Wilcox, R. G., Schunemann, H. J., Ohman, E. M.
(2004). Thrombolysis and Adjunctive Therapy in Acute Myocardial Infarction: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest
126: 549S-575S
[Abstract][Full Text]
Keeley, E. C., Grines, C. L.
(2004). Primary Percutaneous Coronary Intervention for Every Patient with ST-Segment Elevation Myocardial Infarction: What Stands in the Way?. ANN INTERN MED
141: 298-304
[Abstract][Full Text]
Writing Committee Members, , Antman, E. M., Anbe, D. T., Armstrong, P. W., Bates, E. R., Green, L. A., Hand, M., Hochman, J. S., Krumholz, H. M., Kushner, F. G., Lamas, G. A., Mullany, C. J., Ornato, J. P., Pearle, D. L., Sloan, M. A., Smith, S. C. Jr, Task Force Members, , Antman, E. M., Smith, S. C. Jr, Alpert, J. S., Anderson, J. L., Faxon, D. P., Fuster, V., Gibbons, R. J., Gregoratos, G., Halperin, J. L., Hiratzka, L. F., Hunt, S. A., Jacobs, A. K., Ornato, J. P.
(2004). ACC/AHA guidelines for the management of patients with ST-Elevation myocardial infarction--executive summary: A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (writing committee to revise the 1999 guidelines for the management of patients with acute myocardial infarction) . J Am Coll Cardiol
44: 671-719
[Full Text]
Antman, E. M., Anbe, D. T., Armstrong, P. W., Bates, E. R., Green, L. A., Hand, M., Hochman, J. S., Krumholz, H. M., Kushner, F. G., Lamas, G. A., Mullany, C. J., Ornato, J. P., Pearle, D. L., Sloan, M. A., Smith, S. C. Jr, Antman, E. M., Smith, S. C. Jr, Alpert, J. S., Anderson, J. L., Faxon, D. P., Fuster, V., Gibbons, R. J., Gregoratos, G., Halperin, J. L., Hiratzka, L. F., Hunt, S. A., Jacobs, A. K., Ornato, J. P.
(2004). ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction--Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1999 Guidelines for the Management of Patients With Acute Myocardial Infarction). Circulation
110: 588-636
[Full Text]
Kloner, R. A., Rezkalla, S. H.
(2004). Cardiac protection during acute myocardial infarction: Where do we stand in 2004?. J Am Coll Cardiol
44: 276-286
[Abstract][Full Text]
Grines, C. L., O'Neill, W. W.
(2004). Rescue angioplasty: Does the concept need to be rescued?. J Am Coll Cardiol
44: 297-299
[Full Text]
Costantini, C. O., Stone, G. W., Mehran, R., Aymong, E., Grines, C. L., Cox, D. A., Stuckey, T., Turco, M., Gersh, B. J., Tcheng, J. E., Garcia, E., Griffin, J. J., Guagliumi, G., Leon, M. B., Lansky, A. J.
(2004). Frequency, correlates, and clinical implications of myocardial perfusion after primary angioplasty and stenting, with and without glycoprotein IIb/IIIa inhibition, in acute myocardial infarction. J Am Coll Cardiol
44: 305-312
[Abstract][Full Text]
Chaitman, B. R., Lim, M. J.
(2004). No reflow and the quest to achieve optimal perfusion during the acute phase of myocardial infarction. J Am Coll Cardiol
44: 313-315
[Full Text]
Wu, W.-C., Gordon, P. C.
(2004). Invasive Management of Patients With ST Elevation Myocardial Infarction With > 12-h Delay in Presentation: The Question Remains Unanswered. Chest
126: 2-4
[Full Text]
Wharton, T. P. Jr, Grines, L. L., Turco, M. A., Johnston, J. D., Souther, J., Lew, D. C., Shaikh, A. Z., Bilnoski, W., Singhi, S. K., Atay, A. E., Sinclair, N., Shaddinger, D. E., Barsamian, M., Graham, M., Boura, J., Grines, C. L.
(2004). Primary Angioplasty in Acute Myocardial Infarction at Hospitals With No Surgery On-Site (the PAMI-No SOS study) versus transfer to surgical centers for primary angioplasty. J Am Coll Cardiol
43: 1943-1950
[Abstract][Full Text]
Mehta, R. H., Harjai, K. J., Grines, L., Stone, G. W., Boura, J., Cox, D., O'Neill, W., Grines, C. L., Primary Angioplasty in Myocardial Infarction (PAMI,
(2004). Sustained ventricular tachycardia or fibrillation in the cardiac catheterization laboratory among patients receiving primary percutaneous coronary intervention: Incidence, predictors, and outcomes. J Am Coll Cardiol
43: 1765-1772
[Abstract][Full Text]
Kastrati, A., Mehilli, J., Nekolla, S., Bollwein, H., Martinoff, S., Pache, J., Schuhlen, H., Seyfarth, M., Gawaz, M., Neumann, F.-J., Dirschinger, J., Schwaiger, M., Schomig, A., STOPAMI-3 Study Investigators,
(2004). A randomized trial comparing myocardial salvage achieved by coronary stenting versus balloon angioplasty in patients with acute myocardial infarction considered ineligible for reperfusion therapy. J Am Coll Cardiol
43: 734-741
[Abstract][Full Text]
Dirksen, M. T, Laarman, G., van 't Hof, A. W.J, Guagliumi, G., Tonino, W. A.L, Tavazzi, L., Duncker, D. J.G.M, Simoons, M. L, on behalf of the PARI-MI Investigators,
(2004). The effect of ITF-1697 on reperfusion in patients undergoing primary angioplasty: Safety and efficacy of a novel tetrapeptide, ITF-1697. Eur Heart J
25: 392-400
[Abstract][Full Text]
Lemos, P. A., Saia, F., Hofma, S. H., Daemen, J., Ong, A. T. L., Arampatzis, C. A., Hoye, A., McFadden, E., Sianos, G., Smits, P. C., van der Giessen, W. J., de Feyter, P., van Domburg, R. T., Serruys, P. W.
(2004). Short- and long-term clinical benefit of sirolimus-eluting stents compared to conventional bare stents for patients with acute myocardial infarction. J Am Coll Cardiol
43: 704-708
[Abstract][Full Text]
Keeley, E. C., Grines, C. L.
(2004). Primary Coronary Intervention for Acute Myocardial Infarction. JAMA
291: 736-739
[Full Text]
Zeymer, U., Vogt, A., Zahn, R., Weber, M. A, Tebbe, U., Gottwik, M., Bonzel, T., Senges, J., Neuhaus, K.-L., for the Arbeitsgemeinschaft Leitende Kardiologisch,
(2004). Predictors of in-hospital mortality in 1333 patients with acute myocardial infarction complicated by cardiogenic shock treated with primary percutaneous coronary intervention (PCI): Results of the primary PCI registry of the Arbeitsgemeinschaft Leitende Kardiologische Krankenhausarzte (ALKK). Eur Heart J
25: 322-328
[Abstract][Full Text]
Cole, J. H., Weintraub, W. S.
(2003). Are Stenting and Glycoprotein IIb/IIIa Blockade of Good Value in Primary Percutaneous Coronary Intervention?. Circulation
108: 2831-2833
[Full Text]
Bakhai, A., Stone, G. W., Grines, C. L., Murphy, S. A., Githiora, L., Berezin, R. H., Cox, D. A., Stuckey, T., Griffin, J. J., Tcheng, J. E., Cohen, D. J., for the CADILLAC Investigators,
(2003). Cost-Effectiveness of Coronary Stenting and Abciximab for Patients With Acute Myocardial Infarction: Results From the CADILLAC (Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications) Trial. Circulation
108: 2857-2863
[Abstract][Full Text]
Antoniucci, D., Rodriguez, A., Hempel, A., Valenti, R., Migliorini, A., Vigo, F., Parodi, G., Fernandez-Pereira, C., Moschi, G., Bartorelli, A., Santoro, G. M., Bolognese, L., Colombo, A.
(2003). A randomized trial comparing primary infarct artery stenting with or without abciximab in acute myocardial infarction. J Am Coll Cardiol
42: 1879-1885
[Abstract][Full Text]
Sadeghi, H. M., Stone, G. W., Grines, C. L., Mehran, R., Dixon, S. R., Lansky, A. J., Fahy, M., Cox, D. A., Garcia, E., Tcheng, J. E., Griffin, J. J., Stuckey, T. D., Turco, M., Carroll, J. D.
(2003). Impact of Renal Insufficiency in Patients Undergoing Primary Angioplasty for Acute Myocardial Infarction. Circulation
108: 2769-2775
[Abstract][Full Text]